Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage

Jiangmei Wang1, Jie Xia1, Ruoqiong Huang1

  • 1The Children's Hospital of Zhejiang University School of Medicine and National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou, 310051, Zhejiang, China.

Stem Cell Research & Therapy
|September 30, 2020
PubMed

Insights

Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) modulate macrophage polarization, offering a promising cell-free therapy for inflammatory and immune-related diseases.

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) possess regenerative and immunomodulatory properties.
  • MSC-derived extracellular vesicles (MSC-EVs) mimic parental cell functions by transferring bioactive molecules.
  • MSC-EVs interact with macrophages, key regulators of immune responses.

Purpose of the Study:

  • To review the mechanisms of macrophage polarization.
  • To explore the role of MSC-EV-induced macrophage polarization in various diseases.
  • To highlight MSC-EVs as a potential cell-free therapeutic strategy.

Main Methods:

  • Literature review on MSC-EVs and macrophage polarization.
  • Analysis of studies investigating MSC-EV effects on M1/M2 macrophage phenotypes.
  • Synthesis of evidence linking MSC-EV-mediated polarization to disease outcomes.

Main Results:

  • MSC-EVs can suppress M1 macrophage polarization and/or promote M2 polarization.
  • This modulation impacts disease progression in cardiovascular, pulmonary, digestive, renal, and central nervous system conditions.
  • MSC-EVs demonstrate therapeutic potential by influencing immune cell behavior.

Conclusions:

  • MSC-EVs represent a promising cell-free therapeutic alternative to MSCs.
  • Their ability to modulate macrophage polarization is crucial for treating immune-mediated diseases.
  • Further research into MSC-EVs could lead to novel treatments for inflammatory conditions.